The agreement also states that Eli Lilly and Novo Nordisk will guarantee Most Favored Nation (MFN) prices to all new medications that they bring to the market
Like any new medication you anticipate taking in the new year, you may wish to keep it in mind when choosing plans during Fall Open Enrollment
Finally, we convened a meeting of officials from ten states (Arizona, Massachusetts, Minnesota, New Jersey, New Mexico, Pennsylvania, Tennessee, Texas, Virginia, and Wisconsin), all of which are building or refining integration models based on DSNPs
Lilly's Zepbound and Novo's Wegovy are injectable weight-loss drugs that have accelerated global demand for weight-loss medications
A.CamposT.PellegrinetL.KupczakS.et al (2020)